Dr. Kathleen Welsh Bohmer

Biography

Kenneth Anne Welsh-Bohmer is a Professor of Psychiatry and Behavioral Sciences at Duke University, holding secondary appointments in Neurology and Psychology. As a clinically trained neuropsychologist, Dr. Welsh-Bohmer's research predominantly focuses on developing effective prevention and treatment strategies to delay the onset of cognitive disorders. She directed the Joseph and Kathleen Bryan Alzheimer’s Center, overseeing neuropsychology and scientific operations for a groundbreaking Phase III global clinical trial aimed at delaying the onset of early clinical symptoms of Alzheimer’s disease known as the 'TOMMORROW' study, which concluded in 2018. Currently, she directs the Alzheimer's disease therapeutic area at the Duke Clinical Research Institute and actively collaborates with VeraSci, a Durham-based company, on the development of reliable digital cognitive functional assessment tools for early-stage Alzheimer’s related dementias. Her innovative work addresses the information void in the early pre-clinical stages of Alzheimer's disease, with far-reaching implications for clinical practice and the acceleration of global clinical trials aiming to prevent related dementias.

Research Interests

Experience